CTOs on the Move


 
Inogen`s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae`s Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.inogen.com
  • 326 Bollay Drive
    Goleta, CA USA 93117
  • Phone: 855.631.2438

Executives

Name Title Contact Details

Similar Companies

Element Science

Element Science is a San-Francisco based medical device and digital health start-up that develops lifesaving wearable solutions designed to deliver an outstanding experience.

Specialty Medical Supplies Inc

Specialty Medical Supplies Inc is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osypka Medical

Osypka Medical, Inc. is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuo Therapeutics

Nuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing. The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure ulcers (bedsores).

Prudent Choice

Prudent Choice is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.